Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 115,704
  • Shares Outstanding, K 29,975
  • Annual Sales, $ 71,350 K
  • Annual Income, $ -30,190 K
  • 60-Month Beta 2.44
  • Price/Sales 1.57
  • Price/Cash Flow N/A
  • Price/Book 3.22
Trade STIM with:

Options Overview Details

View History
  • Implied Volatility 175.13% ( -50.71%)
  • Historical Volatility 66.06%
  • IV Percentile 80%
  • IV Rank 12.57%
  • IV High 1,379.23% on 11/07/23
  • IV Low 2.08% on 05/18/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 540
  • Open Int (30-Day) 603

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.33
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.37
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +13.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.69 +1.63%
on 04/24/24
5.07 -26.03%
on 04/01/24
-0.48 (-11.35%)
since 03/22/24
3-Month
2.77 +35.38%
on 02/29/24
5.07 -26.03%
on 04/01/24
+0.30 (+8.70%)
since 01/24/24
52-Week
1.03 +264.08%
on 10/30/23
5.07 -26.03%
on 04/01/24
+1.53 (+68.92%)
since 04/24/23

Most Recent Stories

More News
Neuronetics: Q4 Earnings Snapshot

Neuronetics: Q4 Earnings Snapshot

STIM : 3.75 (-2.85%)
Neuronetics: Q3 Earnings Snapshot

Neuronetics: Q3 Earnings Snapshot

STIM : 3.75 (-2.85%)
Neuronetics: Q2 Earnings Snapshot

Neuronetics: Q2 Earnings Snapshot

STIM : 3.75 (-2.85%)
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 2.56% and 2.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STIM : 3.75 (-2.85%)
SIEN : 0.1740 (-18.69%)
Neuronetics: Q1 Earnings Snapshot

Neuronetics: Q1 Earnings Snapshot

STIM : 3.75 (-2.85%)
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 30.23% and 9.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

STIM : 3.75 (-2.85%)
AWH : 3.40 (+0.29%)
Neuronetics: Q4 Earnings Snapshot

Neuronetics: Q4 Earnings Snapshot

STIM : 3.75 (-2.85%)
5 Winning Medical Product Stocks That Still Have Room to Run

Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain from...

CAH : 103.54 (+0.16%)
STIM : 3.75 (-2.85%)
SILK : 17.57 (-0.57%)
TMDX : 88.88 (-1.90%)
OLK : 22.43 (+1.04%)
Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year?

Here is how Neuronetics (STIM) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.

STIM : 3.75 (-2.85%)
CABA : 12.96 (-2.70%)
Neuronetics (STIM) Is Up 12.75% in One Week: What You Should Know

Does Neuronetics (STIM) have what it takes to be a top stock pick for momentum investors? Let's find out.

STIM : 3.75 (-2.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 4.08
2nd Resistance Point 3.99
1st Resistance Point 3.87
Last Price 3.75
1st Support Level 3.66
2nd Support Level 3.57
3rd Support Level 3.45

See More

52-Week High 5.07
Last Price 3.75
Fibonacci 61.8% 3.53
Fibonacci 50% 3.05
Fibonacci 38.2% 2.57
52-Week Low 1.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar